Gentilella, R., Pechtner, V., Corcos, A
In 2023 Lilly published results of its phase 2 trial for orforglipron, a once-daily oral drug which achieved up to 14.7% mean weight reduction at 36 weeks, and Pfizer has completed phase 2 trial for its oral drug danuglipron and is now optimising the formulation
Qian M, Wang D, Watkins WE, et al
However, there are no studies showing this works for all medication types, so this may not be accurate
Mounjaro (tirzepatide) has been making headlines as an effective weight loss medication, but can you use it during menopause
PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to map 14 appetite-regulation pathways and reveal whether your genetics favor a faster or slower response